Advanced Drug Delivery Markets (Liposomes, Polymers and Monoclonal Antibodies) Now Available at ReportsnReports

By Marketsandmarkets, PRNE
Wednesday, January 5, 2011

DALLAS, January 6, 2011 - ReportsnReports announces it will carry Advanced Drug Delivery Markets
(Liposomes, Polymers and Monoclonal Antibodies) Research Report in its store.
Drug delivery is evolving at a rapid rate with new drug product formulations
being discovered frequently. Advanced drug delivery deals with developing
solutions for new entities in therapeutic pharmacology such as protein and
peptides and other novel compounds targeting drugs to specific disease sites
including gene therapy. Treatments for chronic conditions and growth in
patient-administered drugs are factors leading to greater focus on
ease-of-use and convenience.

Browse the complete Report at:
www.reportsnreports.com/reports/51801-advanced-drug-delivery-markets-
liposomes-polymers-and-monoclona.html

(Due to the length of this URL, it may be necessary to copy and paste
this hyperlink into your Internet browser's URL address field. Remove the
space if one exists.)

Drug delivery is evolving at a rapid rate with new drug product
formulations being discovered frequently. Advanced drug delivery deals with
developing solutions for new entities in therapeutic pharmacology such as
protein and peptides and other novel compounds targeting drugs to specific
disease sites including gene therapy. Treatments for chronic conditions and
growth in patient-administered drugs are factors leading to greater focus on
ease-of-use and convenience.

Advanced Drug Delivery Markets (Liposomes, Polymers and Monoclonal
Antibodies) details the types of drug delivery systems, technologies and
products utilizing advanced drug delivery systems. The report describes the
industry, its relationship to various healthcare channels, and the trends for
the future.

The advanced drug delivery market is two-fold. First of all it identifies
drug delivery technology. Secondly, it identifies products in the
pharmaceutical arena that utilize those drug delivery technologies. Because
drug delivery technology is an integral part of sales of pharmaceuticals and
drug delivery technology cannot exist without pharmaceuticals, revenues have
been reported that include pharmaceutical sales. This report will provide
market data that includes the pharmaceutical revenues of those products that
utilize advanced drug delivery.

In this report, the advanced drug delivery market is divided into three
main segments and market estimates are provided for indications within each
category:

    - Liposome Drug Delivery (by Indication - Fungal Infections Cancer,
      Others)
    - Polymer Drug Delivery (by Indication - Cancer, Neutropenia, Hepatitis,
      Contraception, Schizophrenia, Acromegaly and Others)
    - Monoclonal Antibodies Drug Delivery (by Indication - Arthritis,
      Cancer, Multiple Sclerosis, Macular Degeneration, Respiratory
      Syncytial Virus, Others)

The following types of polymer delivery drugs are segmented within this
report:

    - PEGylated Delivery
    - Emulsuion Delivery
    - Injectable Delivery
    - Nanoparticle Delivery
    - Others

A wide range of trends and issues that will impact the advance drug
delivery market are discussed in the report including the current state of
biotechnolgy expansion, molecular imprinted polymers, hot-melt extrusion,
metallofullerenes, nanotechnology advancements and other emerging Drug
Delivery technologies not yet on the market.

The following companies are profiled in the report:

    - Alkermes, Inc.
    - ALZA Corporation
    - AP Pharma
    - Centocor Ortho Biotech, Inc.
    - Eisai , Inc
    - Elan Corporation, Plc
    - EnColl Corporation, Inc.
    - Enzon Pharmaceuticals, Inc
    - Gilead Sciences, Inc.
    - Nektar Therapeutics
    - PDL BioPharma
    - pSivida Corp
    - SurModics, Inc
    - Tolmar, Inc

The research conducted by Kalorama Information included comprehensive
research of primary and secondary sources such as interviews with company
executives, company literature, databases, investment reports, and medical
and business journals. New technologies, market developments, and research
and development trends and expenditures were identified through patent and
data-based searches, as well as via interviews with key personnel.
Person-to-person and telephone interviews were the primary method of
gathering information. E-mail correspondence was also used in the interview
process. Interviews with 24 key industry officials, trade association
spokespersons, consultants, healthcare providers, and government personnel
were compiled to form the primary basis of information - particularly revenue
and market share data- presented in this report.

Related Reports

Laboratory Information Systems (LIS / LIMS) Markets
(www.sandlerresearch.org/reports/51799-laboratory-inform.html)

Sample Preparation and Library Preparation for DNA Sequencers (Results of
The Kalorama Survey of Labs)
(www.sandlerresearch.org/reports/51800-sample-preparatio.html)

Worldwide Point of Care Diagnostic Test Markets
(www.sandlerresearch.org/reports/51802-worldwide-point-o.html)

DNA Sequencing Market Trends (Kalorama Survey of Lab Using Next-Gen and
Capillary Systems)
(www.sandlerresearch.org/reports/42637-dna-sequencing-ma.html)

Catering Trends in U.S. Foodservice
(www.sandlerresearch.org/reports/51803-catering-trends-i.html)

Education Foodservice Market in the U.S.: Elementary, Secondary and
Higher Education, The
(www.sandlerresearch.org/reports/51804-education-foodser.html)

Food Flavors and Ingredients Outlook 2011, 8th Edition
(www.sandlerresearch.org/reports/51805-food-flavors-and-.html)

Frozen Convenience Foods in the U.S.
(www.sandlerresearch.org/reports/42640-frozen-convenienc.html)

All market data pertains to the worldwide market at the manufacturers'
level and was measured in U.S. dollars. The base year for data was 2010.
Historical data are provided for 2006 through 2009, with forecast data
provided for 2010 through 2014. Compound annual growth rates (CAGR) are
provided for the 2006-2010, 2010-2014 and 2006-2014.

About Us

ReportsnReports comprises an online library of 10,000 reports, in-depth
market research studies of over 5000 micro markets, and 25 industry specific
websites. Our client list boasts almost all well-known publishers of such
reports across the globe. We as a third-party reseller of market research
reports employ a number of marketing tools, such as press releases,
email-marketing and effective search-engine optimization techniques to drive
revenues for our clients. We also provide 24/7 online and offline support
service to our customers.

    Contact:

    Ms. Sunita
    7557 Rambler road,
    Suite 727, Dallas, TX 75231
    Tel: +1-888-989-8004
    www.reportsnreports.com/
    www.webmarketingindia.org/article/

Ms. Sunita, 7557 Rambler road, Suite 727, Dallas, TX 75231, Tel: +1-888-989-8004

Business News

MarketsandMarkets News

YOUR VIEW POINT
NAME : (REQUIRED)
MAIL : (REQUIRED)
will not be displayed
WEBSITE : (OPTIONAL)
YOUR
COMMENT :